| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.034 | 0.5 |